Medici Firma Venture Launches $950 Million Venture Capital Fund

New York, United States, April 11, 2016 (Newswire.com) - New York, United States, April 9, 2016 (Newswire) -Medici Firma Venture, a leading investment firm focused on the healthcare sector, announced the closing of its next venture capital fund, MF Venture Private Investments Infinity, LP, with $950 million in limited partner commitments. Investors in the fund include some of the preeminent medical research institutions globally, along with leading endowments, foundations and sovereign wealth funds.

Consistent with its predecessor funds, the new fund will invest in all stages and sectors of the healthcare industry, with a focus on biopharmaceuticals, medical devices, diagnostics and healthcare IT companies located in North America and Europe. The new fund is expected to invest in approximately 30 portfolio companies in amounts generally ranging from $10 million to $75 million.

Medici Firma Asia Venture Capital Fund is expanding into the Silicon Valley with deep industry connections.

Phil Nichols, PR Manager

Karl Modi, a Partner at Medici Firma and Co-Head of Global Private Equity, noted, "The increasing pace of translation of science to medicine creates exciting opportunities for the Fund in areas such as oncology, central nervous system disease, and gene editing."

"With this Fund we plan to accelerate our collaborations with leading life sciences entrepreneurs, strategic companies, research institutions and physicians, to drive the creation of novel therapies that address unmet medical needs," commented Marcus Allen, also an Medici Firma Partner and Co-Head of Global Private Equity.

About Medici Firma

Medici Firma is an institutional venture capital firm that governs itself with onward thinking and a mission to put allied prosperity first.​